Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT05010200
Title The Safety and Tolerability of PGV001-based Personalized Multi-peptide Vaccines in the Adjuvant Setting. (PGV-Prostate)
Recruitment Recruiting
Gender male
Phase Phase I
Variant Requirements Yes
Sponsors Ashutosh Kumar Tewari
Indications

prostate adenocarcinoma

Therapies

CDX-301 + PGV 001 + Poly ICLC

PGV 001 + Poly ICLC

Age Groups: adult | senior
Covered Countries USA

Additional content available in CKB BOOST